Takeda Pharmaceutical Company Limited (武田薬品工業株式会社, Takeda Yakuhin Kōgyō Kabushiki-gaisha) (TYO: 4502) is the largest pharmaceutical company in Japan and Asia and a top 15 pharmaceutical company, employing over 19,000 employees and achieving $15.7 billion USD in revenue during the 2008 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary Millen...
more
Takeda Pharmaceutical Company Limited (武田薬品工業株式会社, Takeda Yakuhin Kōgyō Kabushiki-gaisha) (TYO: 4502) is the largest pharmaceutical company in Japan and Asia and a top 15 pharmaceutical company, employing over 19,000 employees and achieving $15.7 billion USD in revenue during the 2008 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary Millennium: The Takeda Oncology Company.
Takeda Pharmaceuticals was first founded on June 12, 1781 and was incorporated on January 29, 1925.
In 1977, Takeda first entered the U.S. pharmaceutical market by developing a joint venture with Abbott Laboratories called TAP Pharmaceuticals. Through TAP Pharmaceuticals, Takeda and Abbott launch blockbusters Lupron (leuprolide) in 1985 and Prevacid (lansoprazole) in 1995.
One of the firm's mainstay drugs is Actos, a compound in the thiazolidinedione class of drugs used in the treatment of Type 2 Diabetes....
less
